Inventor
RODECK ULRICH
US11 patents
⚠️ This page may combine multiple inventors who share the name “RODECK ULRICH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOPE CITY
7 patentsUS10357571B2Jul 23, 2019
Development of masked therapeutic antibodies to limit off-target effects
HOPE CITY18 citations92
US10689423B2Jun 23, 2020
CTLA4-binding protein peptide-linker masks
HOPE CITY2 citations72
US10414814B2Sep 17, 2019
Tumor-selective CTLA-4 antagonists
HOPE CITY2 citations72
US11311622B2Apr 26, 2022
Development of masked therapeutic antibodies to limit off-target effects
HOPE CITY1 citations71
US11279752B2Mar 22, 2022
Tumor-selective CTLA-4 antagonists
HOPE CITY0 citations62
US11926652B2Mar 12, 2024
CTLA4-binding protein peptide-linker masks
HOPE CITY0 citations61
US11186642B2Nov 30, 2021
Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies
HOPE CITY0 citations61
WISTAR INST
3 patentsUS5470571ANov 28, 1995
Method of treating human EGF receptor-expressing gliomas using radiolabeled EGF receptor-specific MAB 425
WISTAR INST86 citations95
US5633142AMay 27, 1997
WT1 monoclonal antibodies and methods of use therefor
WISTAR INST43 citations93
US5622835AApr 22, 1997
WT1 monoclonal antibodies
WISTAR INST41 citations89